Answers are grounded in this paper and cite their sources.
BACKGROUND: Ga radiolabeled to a variety of radiotracers that evaluate perfusion and organ function, and target specific biomarkers found on tumor lesions such as prostate-specific membrane antigen, somatostatin, fibroblast activation protein, bombesin, and melanocortin. MAIN BODY: Ga radiopharmaceutical production. CONCLUSION: Ga radiopharmaceuticals is presented to highlight potential challenges and opportunities facing the community.
No takes yet. Share an insight, caveat, or question.
Nelson et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: